The role of ATGL-1 in CeTOR regulated longevity in C. elegans by Hechter, Drake
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Boston University Theses & Dissertations
2020
The role of ATGL-1 in CeTOR






































Submitted in partial fulfillment of the 
 
requirements for the degree of 
 








































© 2020 by 
 DRAKE HECHTER 







First Reader   
 Konstantin Kandror, Ph.D. 
 Professor of Biochemistry 
 
 
Second Reader   
 Nava Zaarur, Ph.D. 
 Senior Research Scientist 
 
 
Third Reader   
 Jude T. Deeney, Ph.D. 
















I am thankful for the knowledge and connections I have gained throughout my time at 
Boston University in the Nutrition and Metabolism program. A huge thank you Dr. 
Moore, Dr. Deeney, Dr. Spartano and Dr. Pickering. Your contagious passion, 
determination and love for the field will remain with me always. Thank you to Dr. 
Kandror for allowing me to join the lab and for your guidance during this project. Toli, 
Debasish and, of course, Nava, thank you so much for your patience and expertise. This 




THE ROLE OF ATGL-1 IN CeTOR REGULATED LONGEVITY IN  
C. ELEGANS  
DRAKE HECHTER 
ABSTRACT 
 Aging is a major risk factor for many chronic diseases and a complex biological 
phenomenon. The most well studied and characterized pathways involved in metabolism 
and known to regulate longevity include sirtuins, AMP-activated protein kinase, insulin-
like growth factor (IGF) and the mechanistic target of rapamycin (mTOR).1 These 
signaling pathways and related transcriptional factors are evolutionarily conserved from 
yeast to primates.  
Evidence suggests adipose tissue plays an important role in the regulation of 
lifespan particularly through energy homeostasis during times of scarcity and excess. Our 
laboratory has shown adipose triglyceride lipase (ATGL), the rate-limiting enzyme within 
the lipolytic pathway, is the target of dietary restriction and insulin/IGF-1 signaling 
pathways, both of which regulate lifespan.22 Given the convergence and necessity of 
ATGL-1 in the longevity response of dietary restriction and reduced insulin/IGF1 signaling 
pathways and the uncertainty of the downstream effects TOR has on longevity, we 
hypothesize that ATGL-1 plays an important role in CeTOR regulated longevity in C. 
elegans.  
This investigation was carried out by (a) determining whether levels of ATGL-1 
are influenced by TOR inhibition via rapamycin and TOR specific RNA interference 
(RNAi) and (b) examining the role of ATGL-1 in CeTOR regulated longevity in C. 
	
	 vii 
elegans. We have found that rapamycin treatment does not increase expression of ATGL-
1::GFP in C. elegans, however, continued research with CeTOR inhibition using 
rapamycin and RNAi treatment is necessary. The RNAi and longevity experiments need to 
be conducted.  
Tissue specific regulation of ATGL expression has been shown to be implicated in 
chronic disease and in longevity. However, there are still many insights to be discovered 
and understood about its role in longevity pathways, including feedback mechanisms and 
second messengers lipolytic products play. Elucidating the downstream effects of ATGL 
within model organisms will impact future chronic disease research and longevity studies. 
Given that these pathways are widely evolutionarily conserved, future findings will aid in 
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I. Longevity/Aging Regulation  
Aging is a major risk factor for many chronic diseases and a complex biological 
phenomenon. Many genes and pathways have been discovered to modulate aging and 
longevity, however, the complete mechanism by which these pathways affect longevity 
requires further research. Aging is subject to regulation by signaling pathways and 
transcriptional factors that are evolutionarily conserved from yeast to primates. The most 
well studied and characterized pathways known to regulate longevity with regard to 
metabolism include sirtuins, AMP-activated protein kinase, Insulin-like growth factor 
(IGF) and the mechanistic target of rapamycin (mTOR).1 Mediators of lifespan and health-
span extension are found within nutrient and stress sensors,2 thus, energy homeostasis plays 
a vital role in the regulation of longevity. For example, dietary restriction is the best-known 
signal to extend lifespan across organisms.2,8 
In the mammalian organism, adipose tissue is largely responsible for energy 
homeostasis.3 Given the storage capacity and elasticity of adipose tissue, control of 
lipolysis, the process by which triglycerides are broken down, is crucial for energy 
partitioning and balance.4,5 The accumulation of excess adipose tissue is associated with 
aging and other diseases such as diabetes, hypertension, cancer and neurodegenerative 
diseases. There is a negative correlation between fat and longevity. Decreasing and/or 
surgical removal of adipose tissue stores have been shown to increase longevity. Previous 
studies have shown that mutations affecting fat mass and/or removal of visceral fat 
increases lifespan.6 Energy homeostasis is a complex process that requires multiple 
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signaling cascade networks which detect and respond to nutrient availability. These 
networks play an essential role for life and have been shown to mediate lifespan.7  
II. Adipose Triglyceride Lipase (ATGL) 
Under readily available nutrient conditions, insulin stimulates the uptake of glucose 
and free fatty acids, inhibits lipolysis and stimulates de novo fatty acid synthesis within 
adipose tissue. In addition, through control of gene expression of fat-specific transcription 
factors such as SREBP-1c and PPAR𝛾, insulin regulates growth and differentiation of 
adipose tissue.9 During lipolysis, free fatty acids are released from adipocytes and are 
transported to other tissues where they can be used as fuel via fatty acid oxidation. 
Complete hydrolysis of triglycerides to glycerol and free fatty acids is accomplished by tri, 
di- and mono-acylglyceride lipases. These lipases are adipose triglyceride lipase (ATGL), 
hormone-sensitive lipase (HSL) and monoacylglycerol lipase (MGL), which act on 
triglycerides, diacylglycerides and mono-acylglycerides, respectively, and release a free 
fatty acid during each step. ATGL has been found to be the rate-limiting enzyme within in 
the lipolytic pathway.4 The expression of ATGL is regulated by upstream targets such as 









Figure 1. (A) Simplified diagram of the Insulin/Insulin-like Growth Factor 1 signaling 
(IIS) pathway. (B) TORC1 and FoxO1 regulation of ATGL expression. DR, Dietary 
Restriction.   
 
Inhibition of lipolysis and promotion of triglyceride storage within adipose tissue 
is largely controlled by insulin. Impaired insulin response within individuals who are 
insulin resistant and/or type 2 diabetic result in high levels of circulating free fatty acids. 
These free fatty acids are picked up and stored within non-adipose peripheral tissues.10 
Accumulation of lipids within non-adipose tissue can lead to lipotoxicity which can have 
a number of adverse effects including endothelial dysfunction, insulin resistance and 
pancreatic β-cell death.10,11 Therefore, adipose tissue and control of the lipolytic pathway, 
specifically through the rate-limiting enzyme, ATGL, is important for energy homeostasis 
and longevity.  
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The “critical nodes”14 within the insulin/insulin-like growth factor 1 signaling (IIS) 
pathway that are responsible for the longevity response seen in model organisms are FoxO1 
and TORC1, both of which have been shown to control the expression of ATGL.3,4,18,24,40 
Given the convergence and necessity of ATGL-1 in the longevity response of dietary 
restriction and reduced insulin/IGF1 signaling pathways, as well as the uncertainty 
regarding the downstream effects of TOR on longevity, we hypothesize that ATGL-1 plays 
an important role in CeTOR regulated longevity in C. elegans.  
 
III. Insulin/Insulin-like Growth Factor 1 Signaling (IIS) Pathway  
The IIS pathway plays a major role in the longevity response and is regulated by 
nutrient availability. During nutrient scarce conditions, catecholamines are released by the 
sympathetic nervous system to activate lipolysis. Stimulation of the 𝛽-adrenergic receptor 
on adipocytes activate adenylyl cyclase (AC) which elevates the levels of cAMP and 
increases protein kinase A (PKA) activity. PKA initiates lipolysis by direct 
phosphorylation of hormone-sensitive lipase (HSL) and perilipin as well as through 
indirect activation of ATGL.4,15 
During nutrient rich conditions, the IIS receptor acts through insulin receptor 
substrate 1 (IRS-1), which recruits and activates PI3K. The increase in phosphatidylinositol 
phosphate 3 (PIP3) near the plasma membrane by PI3K activates the serine/threonine 
kinases PDK-1 and protein kinase B (PKB/Akt), which phosphorylate and inhibit tuberous 
sclerosis complex (TSC) made up of TSC1 and TSC2. TSC acts as a GTPase-activating 
protein (GAP) on Rheb (Ras homolog enriched in brain). Rheb is a small key GTPase 
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upstream activator of TORC1 which directly binds with TORC1 and, in the GTP-bound 
form, stimulates its kinase activity. Therefore, phosphorylation and inactivation of TSC 
allows Rheb to activate TORC1 signaling (Figure 1A).13,14,16,50 
 
Critical Nodes within the IIS Pathway 
3.1 FoxO 
Transcription factors are also regulated by the IIS pathway. The Forkhead box O 
(FoxO) family of transcription factors alter gene expression and have been shown to have 
effects on longevity. These FoxO transcription factors are conserved from C. elegans to 
mammals. Within mammalians, they have a number of functions such as tumor 
suppression, stress resistance, DNA damage repair, cell cycle regulation and energy 
homeostasis. FoxO proteins promote gluconeogenesis and enhance food intake, thus are 
critical in energy metabolism. FoxO1 has proven to be an important regulator of lipid 
homeostasis and triglyceride partitioning between different tissues. FoxO1 stimulates 
VLDL production within the liver, boost lipid oxidation in skeletal muscle and increases 
lipolysis in adipose tissue. These actions work in concert to regulate lipid homeostasis.4   
Changes in subcellular localization is the major mechanism by which FoxO 
transcription factors are regulated.3 This is accomplished through post-translational 
modifications particularly through acetylation, mono- and polyubiquitination and 
phosphorylation. Most notably of the FoxO family, FoxO1 has been found to play a central 
role in the regulation of metabolism within several cell types. More specifically, FoxO1 
increases the rate of lipolysis by increasing the expression of ATGL.4  
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Activation of the IIS pathway by insulin, inhibits the expression of ATGL in 
adipose tissue. Phosphorylation of FoxO1 by PKB/Akt renders the transcription factor 
unable to enter the nucleus and sequesters it within the cytoplasm, thereby preventing 
FoxO1 from modifying gene expression.4,17 In contrast, when this pathway is not active, 
such as under low nutrient availability, FoxO1 can enter the nucleus to transcribe target 
genes such as ATGL (Figure 1).13,14  
3.2 Target of Rapamycin (TOR)  
The other major nutrient sensing pathway and critical node is TOR. TOR functions 
as the master regulator of cellular growth and metabolism in response to nutrient as well 
as hormonal cues. It has also been implicated in diseases such as diabetes, cardiac 
hypertrophy, cancer, neurodegenerative syndromes and aging. TOR has two complexes, 
complex 1 and 2 (abbreviated as TORC1 and TORC2), which function in distinct ways and 
regulate different downstream processes. TORC1 and TORC2 are defined by their 
association with Raptor and Rictor, respectively.16  
The multi-function of TORC1 make the complex a key regulatory nexus which 
responds to nutrients, hormones and cellular energy status balancing anabolic and catabolic 
processes.12 Amino acids, oxygen, energy and growth signals activate TORC1, which 
regulates lysosomal biogenesis, ribosomal biogenesis, cap-dependent translation, 
thermogenesis, protein and lipid synthesis and autophagy.18,22 Previous research in C. 
elegans and mice has demonstrated that post-developmental inhibition of TORC1 results 
in adult life extension. Consistent with the role of TOR, knockdown of TORC1 also 
enhances environmental stress tolerance.16 Within C. elegans, TORC1 inhibition results in 
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reduced mRNA translation as well as has a positive effect on lifespan partially through 
DAF-16/FoxO and SKN-1 (ortholog of mammalian Nrf1/2/3 proteins). These transcription 
factors regulate genes that protect against environmental, metabolic and proteotoxic stress 
as well as promote longevity.18,19 TORC1 suppresses lipolysis within adipocytes through 
the immediate-early response transcription factor (Egr-1), which directly inhibits ATGL 
gene expression.20  
The biological functions of TORC2 are not well understood, although evidence 
indicates that it is also important for growth.19 TORC2 signaling is responsive to growth 
factors mediated by PI3K but is insensitive to nutrients.15,21 Glucose uptake in response to 
insulin involves TORC2 phosphorylation of Akt at Serine position 473, which is required 
for Akt activity on AS160.15 3 
 
IV. C. elegans as a Model Organism  
The functionality of adipose tissue and lipid droplets is conserved between many 
species including drosophila, mammals and C. elegans. Complete genome sequencing of 
the nematode reveals not only the evolutionarily conservation of the genes involved in 
lipolysis and fatty acid synthesis but also the nutrient sensing and energy homeostasis 
signaling pathways such as the IIS and CeTOR. C. elegans express the insulin receptor 
(DAF-2) and have evolutionarily homologues of FoxO (DAF-16) and TOR kinase (LET-
363) (Figure 2). The worms lack defined adipose tissue, however, they store fat within 
their intestine which appear to function and store lipid droplets efficiently.27,34 The 
nematodes have proven to be excellent model organisms for energy homeostasis, 
specifically within lipid droplets, as well as longevity studies. The frequently used wildtype 
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Bristol strain N2 have an average lifespan of approximately 20 days. This short lifespan 
contributes to the convenience of using these nematodes as a model organism for longevity 
experiments. 
Fertilization to hatching at room temperature occurs in approximately 12 hours and 
the resulting first-stage larva contain about 550 cells. Adulthood is reached in ~3 days after 
the newly hatched larvae progress through four larval molts. The pharynx and intestine 
make up the inner tube which is surrounded by a fluid-filled hydrostatic body cavity and 
the outer tube is made up of the musculature, hypodermis and collagenous cuticle. This 
simple anatomy of C. elegans contributes to its use as a model organism.28  
The lifespan of C. elegans can be extended by a number of treatments or mutations 
demonstrating that it is an important model organism for longevity research. These 
manipulations shift cells from states favouring growth to states of maintenance and stress 
resistance. TOR signaling, dietary restriction, FoxO/DAF-16, SKN-1/Nrf, heat-shock 
factor, sirtuins and c-Jun N-terminal kinase (JNK) have been shown to influence the 
lifespan of C. elegans.26,53 In addition, the ability to utilize pharmacological agents such as 






Figure 2. Regulation of ATGL expression in mammals and C. elegans.  
 
 
Studies using fluorescence microscopy have indicated that ATGL-1::GFP are 
localized on the surface of lipid droplets in overexpressed ATGL-1 (orthologue of 
mammalian ATGL) mutant and wildtype C. elegans, which are distinct from the natural 
auto-fluorescent lysosomal organelles the worms contain.29,30 ATGL-1::GFP which 
contain overexpressed levels of ATGL-1, have an average lifespan of about 28 days, a 40% 
lifespan increase when compared to wildtype. It was also shown that ATGL-1 is required 
for the longevity effects of both daf-2-induced (ortholog of mammalian insulin receptor) 
and dietary restriction, and that ATGL-1 is regulated by the DAF-2/DAF-16 (Insulin 
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receptor/FoxO) axis (Figure 3). These results suggest that the life extension response of 
reduced insulin/insulin-like growth factor 1 signaling (IIS) and dietary restriction pathways 















Figure 3. Expression of ATGL-1 is regulated by the daf-2/daf-16 pathway (A). The 
lifespan of different C. elegans strains. The ATGL-1 loss-of-function mutant suppresses 








V. TOR inhibition on Longevity  
 Rapamycin, dietary restriction and TOR inhibition via drug treatment and/or 
genetic modification appear to promote longevity at least partially through reduced mRNA 
translation.18 Rapamycin treatment has been shown to extend lifespan in yeast, worms, flies 
and mice. Though it was first thought that the longevity effects of rapamycin were through 
inhibition of TORC1, evidence indicates sustained rapamycin treatment also reduces 
TORC2 activity, thus some of its effects on longevity may involve both TOR 
complexes.18,19 Data has illustrated that the IIS and TOR pathways influence longevity via 
regulation of SKN-1 and DAF-16. It is largely accepted that DAF-16/FoxO is not required 
for lifespan extension by reduced TOR activity or most dietary restriction interventions.18 
Inhibition of TOR via RNAi has been shown to extend lifespan independently of daf-16, 
suggesting that TOR may act in a pathway distinct from the IIS. However, it has been 
postulated that these two pathways converge downstream of DAF-16 as TOR RNAi does 
not further extend lifespan of daf-2 mutants.18  
 Rapamycin upregulated genes activated by genetic TORC1 inhibition as well as 
genes that encode TORC1 pathway components in C. elegans. Similar to results from 
mammalian cells lines, it is suggested that rapamycin promotes longevity in C. elegans by 
interfering with both TOR complexes.26 However, the downstream effects of TOR that 






VI. RNAi  
 RNA interference also called Post-Transcriptional Gene Silencing (PTGS) is a 
conserved biological response to double-stranded RNA that mediates resistance to both 
endogenous parasitic and exogenous pathogenic nucleic acids and regulates gene 
expression.31 RNAi is a specific, rapid and simple method for determining loss-of-function 
phenotypes of genes in C. elegans and genetic interactions can also be examined.28 
 Microinjection, feeding and soaking to deliver dsRNA are three methods used to 
induce RNAi in C. elegans. The feeding technique is simple and requires no microinjection 
system. Briefly, a cDNA that corresponds to the gene of interest is cloned into a bacterial 
expression vector between opposing phage T7 polymerase promoter sites. This feeding 
vector is then transformed into the E. coli HT115 strain which carries the DE3 lysogen. 
The HT115(DE3) strain contains the gene that encodes for the T7 RNA polymerase but 
lacks RNase III, thus, deficient in degrading dsRNA. The RNAi is prepared and seeded 
onto nematode growth medium (NGM) which contain the inducible factor, IPTG. IPTG is 
required to induce the expression of genes cloned downstream of the T7 promoter.28 This 
study will utilize RNAi to inhibit the entire TOR kinase complex (let-363 in C. elegans). 
 
VII. ATGL-1 in CeTOR Regulated Longevity in C. elegans 
FoxO1 and TOR are “critical nodes”14 within the IIS pathway, are opposingly 
regulated by Akt phosphorylation and convergence of these pathways has been shown to 
be an important mediator of longevity.14 These nutrient sensing pathways converge on the 
regulation of ATGL expression. Research has shown that ATGL is required for lifespan 
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extension,22 and FoxO1 and TORC1 regulate the rate of lipolysis by controlling expression 
of ATGL.4,23,24,25 Thus, the purpose of this investigation is to (a) determine whether levels 
of ATGL-1 is influenced by TOR inhibition using rapamycin and TOR specific RNAi and 
(b) to examine the role of ATGL-1 in CeTOR regulated longevity in C. elegans. 
It is clear adipose tissue plays an important role in the control of lifespan 
particularly through energy homeostasis during times of nutrient scarcity and excess. 
Combining the evidence that dietary restriction and IIS mediated longevity not only 
converge on ATGL activity but also require ATGL, and that TOR controls the expression 
of ATGL, further understanding of the role of ATGL in TOR regulated longevity within 
model organisms is needed. Given that these pathways are widely evolutionarily 
conserved, future findings will aid in understanding regulatory mechanisms of longevity 






I. C. elegans Strains  
All C. elegans strains were maintained at 20ºC following the standard methods.32 
The commonly used Bristol strain N2 was used as the wild-type. The two other strains 
utilized were the VS20 hjIs67 [atgl-1p::atgl-1::gfp + mec-7::rfp], and VC20458 
containing atgl-1 (gk176565) [P87S] III strains, which were obtained from the 
Caenorhabditis Genetics Centre (CGC). The VS20 strain contains chromosome-integrated 
transgenic array hjIs67 [atgl- 1p::atgl-1::GFP+mec-7p::RFP]33 ) and was used to track 
expression of the ATGL-1 protein. This strain will be referred to as atgl-1::gfp. In order to 
get rid of the other mutations and specifically select the atgl-1 mutant, the atgl-
1(gk176565) mutation was outcrossed four times to generate AGK785 atgl-1(gk176565).  
By doing so, these strains can be considered pure from other potential mutations they may 
carry from the nature of the mutagenic process by which they were generated.22  
 
II. C. elegans Maintenance  
 The worms were cultured on 60mm plates. The plates contained the standard 
nematode growth medium (NGM) recipe (3 g of NaCl, 2.5 g of peptone, and 20 g of agar 
and bring to 1 L with H2O; liquid autoclave for 1hr and let cool; 1 mL of cholesterol [5 
mg/mL in ethanol], 1 mL of 1 M CaCl2, 1 mL of 1 M MgSO4, and 25 mL of 1 M [pH 6.0] 
KPO4). The food source used was the standard streptomycin-resistance E. coli strain OP50, 
prepared as described by (Admasu et al., 2018). The worms were transferred to fresh 
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prepared plates weekly. The 150mm plates utilized contained the standard NGM recipe 
with the OP50-1 food source 10x concentrated.  
 
III. Worm Synchronization 
Using the protocol previously described by (Admasu et al., 2018), cultured worms 
from the 60mm plates were chunked onto 150mm pre-seeded NGM plates and left to grow 
until a large number of eggs and gravid adults were present on the plates (2-3 days at 20ºC). 
10-13 mL of M9 buffer (0.3% KH2PO4, 0.6% Na2HPO4, 0.5% NaCl, 1 mM MgSO4) was 
pipetted onto the plate to dislodge and collect the C. elegans by gently swirling. The 
collected nematodes were transferred to a 15 mL tube and treated with 20% alkaline 
hypochlorite solution (8.25mL ddH2O, 3.75 mL 1M NaOH & 3.0 mL bleach). After being 
washed four times with M9 buffer, the embryos were left to hatch in the M9 buffer 
overnight. Hatched worms were harvested and seeded onto fresh 150mm NGM plates and 
left to grow to the adult L4 stage.1,22 
 
IV. Rapamycin and Control Plate Preparation  
 The rapamycin treated plates were prepared on 35mm sized dishes using the 
standard NGM recipe, (as described earlier) with the addition of 100µL 5’-
fluorodeoxyuridine (FUdR) 100 mg/mL (a final concentration of 250µM) and rapamycin, 
dissolved in DMSO at 50 mg/mL and added to a final concentration of 100µM. The FUdR 
was added to the medium to prevent synchronized worms from egg hatching.1 The control 
plates contained FUdR and DMSO instead of rapamycin.  
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V. Rapamycin & Control Plate Seeding  
Approximately 200 synchronized L4 stage N2 and atgl-1::gfp worms were 
harvested and collected from the 150mm NGM plates using M9 buffer and transferred to 
rapamycin or control plates. N2 worms were seeded on one rapamycin and one control 
plate and atgl-1::gfp worms seeded the same in both the 24- and 48-hour treatment groups. 
These plates were cultured at 20ºC for 24- and 48-hours before quantification of ATGL-1.  
 
Quantification of ATGL-1  
 
VI. RT-qPCR  
Following a similar workflow described by (Zaarur et al., 2019), quantification of 
ATGL-1 RNA levels was accomplished using RT-qPCR. Synchronized L4 stage worms 
(roughly 200 worms) were washed by PBS, re-suspended in 1 mL of cold TRIzol (Ambion, 
Austin, TX), incubated at -80ºC and RNA was isolated following the manufacturer’s 
instructions. Reverse transcription (RT) was carried out using a RETROscript kit (Ambion) 
and quantitative RT-PCR was performed using iTag Universal SYBR Green Supermix 
(Bio-Rad, Hercules, CA) following the protocol of manufacturer with the following 
primers. atgl-1: forward 5’ GATCGACCGATGATTTATCGAG 3’, reverse 5’ 
GAGCCAATCCACATTTGGTC 3’; actin-1/3: forward, 5’ 
CACGAGACTTCTTACAACTCC 3’, reverse, 5’GCATACGATCAGCAATTCCT 3’. 




VII. Fluorescence Microscopy  
Approximately 10-15 worms were hand-picked and mounted on 2% agarose pads 
which was positioned on glass microscope slides. The worms were immobilized with a 
drop of sodium azide to aid in accurate and consistent images. 10-14 photographs were 
taken using Zeiss Axiolmager Z1 (Carl Zeiss, Germany) at 20 and 40X magnification. All 
images had identical exposure times when GFP intensity was compared between the 
different conditions. Images of N2 worms were taken in the same fashion to determine the 
level of auto-fluorescence. The calculated mean of the N2 was subtracted from the atgl-
1::gfp in order to quantify the fluorescence of ATGL-1 only. The level of fluorescence 
within the intestine was assessed using ImageJ software. The background of each image 
was accounted for by subtraction. The calculated mean of the N2 worms seeded on DMSO 
and FudR control plates was subtracted from the atgl-1::gfp worms to quantify the 
fluorescence of ATGL-1. In 10 randomly selected images from each group an unpaired 
two-tailed t-test was used to calculate the difference in means between treated and non-
treated worms. 
 
VIII. Western Blot 
The western blot was completed as previously described.34,49 Roughly 200 L4 
synchronized N2 and atgl-1::gfp worms were sonicated in 1 M TSE solution at 20% output, 
30s on 30s off, for eight rounds using the Branson 500 Sonic Dismembrator. The samples 
were then centrifuged at 12 000 rpm and 4ºC (Eppendorf AG 5424) and total protein 
content in the supernatant was quantified using Bradford Dye Reagent (Bio-Rad). Equal 
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amounts of total lysate from each sample was resolved using SDS-PAGE on a 10% gel 
(Invitrogen NuPAGE Bis-Tris) and transferred onto a 2-µm nitrocellulose membrane 
(Thermo Scientific) at 100 mA for 60 mins. The membrane was blocked with 5% (wt/vol) 
skim milk in Tris-buffered saline containing 0.1% (vol/vol) Tween 20 (TBST; 25 mM Tris-
HCl [pH 8.0], 137 mM NaCl, 2.7 mM KCl, and 0.1% Tween 20) at room temperature for 
30 min, then overnight incubation at 4ºC with anti-GFP antibody and anti-actin (Millipore 
MAB1501R) diluted 1:2000 in PBST-3% BSA. Following incubation, the membrane was 
washed with TBST 3 times and hybridized with secondary antibodies conjugated with 
horseradish peroxidase (Sigma-Aldrich) in 5% skim milk dissolved in TBST at room 
temperature for 2 hours. The membrane was then washed with TBST 3 times, incubated 
with enhanced chemiluminescence reagents and quantified with LuminoImager (LAS-
3000) and Science Lab Image Gauge software (Fuji Photo Film). The intensity of each 
band was quantified using ImageJ.34,49 
 
IX. RNAi Feeding 
 Following the RNAi feeding protocol as described by (Kamath et al., 2000) and (Li 
et al., 2018), synchronized L4 staged adults were mounted onto standard NGM plates 
which were seeded with individual dsRNA-expressing bacterial clones. HT115 bacteria 
transformed with either RNAi clones or empty vector pL4440 were grown over night in 
12.5 µg/mL tetracycline and 50 µg/mL ampicillin. Cultures were diluted 1:10 and grown 
to an OD600 of 0.8-1.0 and induced with 0.7 mM IPTG, the following day. This culture 
was used to seed NGM plates containing tetracycline, ampicillin and 1 mM IPTG. RNAi 
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plasmid for let-363(RNAi) has been described in great detail by (Vellai et al., 2003). Given 
that the absence of LET-363/TOR activity causes developmental arrest at L3 larval stage, 
treatment with let-363 double-stranded RNA during adulthood (L4 stage) was used. The 
let-363 RNAi and empty vector control plates made up the experimental and control group 
respectively.  
 
X. Oil-Red-O Staining  
The 200 synchronized L4 stage N2 and atgl-1::gfp worms were harvested from 
their plate. The worms were washed with PBS and fixed in 1 mL of   -20ºC methanol for 5 
mins. Before centrifugation at 1000 rpm for 1 min, 2 mL of PBST (PBS with 0.01% Tween-
20) was added. The supernatant was removed and the C. elegans were washed with PBST 
twice. 60% by volume water was added to Oil Red O (0.5% solution in isopropanol, Sigma) 
for 10 mins at room temperature. The solution was filtered using a 0.4µm syringe filter. 
Filtered 40% isopropanol Oil Red O solution (1 mL) for 20 mins was used to stain fixed 
worms. Stained worms were washed with PBST twice then mounted on slides with 2% 
agar. Images were taken with a colour camera using an inverted epi-fluorescent microscope 
(Carl Zeiss; Axio Observer D1).22  
 
XI. Longevity Experiments  
 The longevity experiment used both the control N2 and the atgl-1 mutant strain. 
Two L4 worms from each strain were picked and mounted onto standard NGM plated with 
OP50 bacteria. This allowed a synchronized generation to be grown. 30 worms from each 
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strain were picked and put onto standard NGM dishes. After 6 hrs many eggs were laid on 
each plate and the adult worms were removed. The hatched L1 larvae, were left for 2 days 
to reach late L3 stage/early L4 stage and the transfers began on that day, noted as day 1. 
200 worms per strain were transferred to their respective plates, rapamycin treated, RNAi 
or control NGM plates. The plates (N = 20 worms per plate) were monitored and worms 
were scored as either live or dead every day. Once the worms stopped responding to 
probing by wired picks, they were considered dead and removed from the plate. Any 
worm(s) that disappeared, was under the agar or died unnaturally were removed and 
excluded from scoring. Unnatural deaths included internal larva hatching and bursting.22  
All plates were kept at 20ºC and surviving worms were transferred to a fresh plate 
every second day to ensure the same worms were being included daily. The maximum 
lifespan was defined as the total time, in days, the worms were recorded as live starting at 
day 1. The time at which 50% of the worm population was alive, was defined as mean 
lifespan. Statistical significance of lifespan between the strains was found using a log rank 














I.  Rapamycin Experiment 
To determine whether levels of ATGL-1 are influenced by CeTOR inhibition by 
rapamycin, quantification of the level ATGL-1 after the 24- and 48-hour treatment was 
conducted. 200 synchronized L4 N2 and atgl-1::gfp C. elegans were each seeded onto two 
rapamycin treated plates and two control plates. This allowed two treatment groups of 24- 
or 48-hours to be made. The 24- and 48-hour groups contained N2 worms seeded onto one 
rapamycin and one control plate and atgl-1::gfp worms seeded on one rapamycin and 
control plate, thus each group contained four plates. After the 24- or 48-hour treatment was 
complete, RT-qPCR was conducted on each plate to determine the ATGL-1 RNA level. 







































Figure 4. Design of the rapamycin and RNAi experiments.  
 
Fluorescence microscopy was conducted after the 24- and 48-hour treatment using 
10-15 hand-picked N2 and atgl-1::gfp C. elegans from each plate then mounted onto their 
own agarose pad positioned on microscope slides. The worms were immobilized with 
sodium azide and 10-14 images per slide were taken using Zeiss Axiolmager Z1 (Carl 
Zeiss, Germany) at 20 and 40X magnification. Images of the N2 worms were taken to 
determine the level of auto-fluorescence. The calculated mean of the N2 was subtracted 
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from the atgl-1::gfp in order to quantify the fluorescence of ATGL-1 only. Each image was 
also corrected for its background fluorescence. Fluorescent ATGL-1::GFP levels corrected 
for N2 auto-fluorescence from the atgl-1::gfp C. elegans after 24-and 48-hours of 
rapamycin or control treatment are shown in Figure 5. The same values collected from N2 
worms seeded on DMSO and FudR control plates were used to correct for auto-
fluorescence of the atgl-1::gfp worms regardless of the treatment time. Using an unpaired 
two-tailed t-test, the corrected fluorescent ATGL-1::GFP levels within the atgl-1::gfp 
rapamycin treated worms were decreased when compared to the atgl-1::gfp control. These 
results were found to be statistically significant after 24-hours but not after 48-hours 
(Figure 5). These results reveal that rapamycin treatment decreased the protein level of 
ATGL-1. These findings could be attributed to small sample size and/or large inter-worm 
variation. Results of the Oil-Red-O staining are critical to obtain to see if lipolysis is 
increased. These results are expected to indicate that CeTOR inhibition by rapamycin result 
in an increase in lipolysis. Using the Oil-Red-O stain as confirmation, a more complete 












Figure 5. Rapamycin treatment does not increase expression of ATGL-1::GFP in C. 
elegans. GFP fluorescence was measured in atgl-1::gfp expressing C. elegans after 
treatment with rapamycin for 24-and 48-hours. Individual worms (10 per slide) were 
randomly selected from 10-14 images taken at 20 and 40X magnification. The intestine of 
each worm was captured during the ImageJ assessment of the level of fluorescence. The 
calculated mean of the N2 worms seeded on DMSO and FudR control plates was subtracted 
from the atgl-1::gfp worms to quantify the fluorescence of ATGL-1. Unpaired two-tailed 
t-test was used to calculate the difference in means between the 24- and 48-hour treatment 
times. The values were found to be significant after 24-hour treatment (p < 0.05 after 24-
hours [p=0. 0.003]), and not statistically significant after 48-hour treatment (p > 0.05 after 




 200 L4 synchronized N2 and atgl-1::gfp plated C. elegans were used to conduct a 
western blot analysis on each plate to determine ATGL-1 protein level. Western blots were 
done following the 24- and 48-hour treatment of rapamycin or control plates.  
The RT-qPCR, fluorescent microscopy and western blot used to quantify ATGL-1 
after CeTOR inhibition via rapamycin are expected to result in an increase lipolysis via 
increased ATGL-1 expression and activity. In order to confirm the effectiveness of the 
rapamycin treatment methodology, to ensure it was performing as expected and increasing 
the rate of lipolysis, Oil-Red-O staining within each of the 24- and 48-hour treated plates 
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was conducted. This was used to detect triglyceride stores. A depletion of these reserves 
indicates an increase in lipolysis. Previous findings published by our laboratory have 
shown dietary restriction of N2 worms for 6-hours depletes triglyceride reserves and up-
regulates atgl-1 mRNA. These results can be seen in Figure 6. 
Figure 6. ATGL-1 is up-regulated by DR. Wild type (N2) and atgl-1::gfp worms split 
into control (Fed) and dietary restricted (DR) groups then stained with Oil-Red-O (A). 
Triglyceride content measured in control (Fed) and DR groups of N2 and atgl-1::gfp 
worms (B). RNA extracted from control (fed) and DR groups and atgl-1 mRNA levels 




Following a similar experimental design and layout as the rapamycin experiment,
CeTOR specific RNAi (let-363) and empty vector control plates were used to make up the 
control and experimental plates. These plates were also divided into two treatment groups 
of 24- and 48-hours. The 24- and 48-hour treatment groups contained four plates, two 
empty vector control plates and two let-363 RNAi plates. 200 L4 N2 and atgl-1::gfp worms 
were seeded onto one treated and one control plate each within each treatment group. After 
the 24- or 48-hour treatment, ATGL-1 quantification methods were performed. Figure 4B 
outlines the design of this experiment.  
ATGL-1 RNA using RT-qPCR and protein quantification by fluorescent ATGL-
1::GFP and western blot were conducted. Similar to the expected results of the rapamycin 
experiment, CeTOR specific RNAi should result in an increase in atgl-1 level and increase 
of lipolysis as indicated by the results of the Oil-Red-O staining. The rate of lipolysis is 
expected to increase as the expression and activity of ATGL-1 is also increased.  
III. Longevity Experiment
Once the ATGL-1 quantification results are found from the rapamycin and RNAi
experiments, the second part of this investigation, to determine the role of ATGL-1 in 
CeTOR regulated longevity in C. elegans, can be examined. Using the N2 and atgl-1 
mutant strain C. elegans, the longevity experiment was conducted. 20 N2 and atgl-1 mutant 
strains were each seeded onto 10 rapamycin and 10 control plates as well as 10 CeTOR 
specific RNAi (let-363) and 10 empty vector control plates. The plates (N = 20 worms per 
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plate) were monitored and worms were scored as either live or dead every day. Once the 
worms stopped responding to probing by wired picks, they were considered dead. The 
experimental design of this experiment is illustrated in Figure 7.  
If ATGL-1 does in fact play a role in CeTOR regulated longevity response in C. 
elegans, the life extending effect of CeTOR inhibition by both rapamycin and RNAi will 
be reduced by atgl inactivation. The maximum lifespan used here is defined as the total 
time, in days, the worms are recorded as live starting at day 1 and the time at which 50% 
of the worm population are alive, is defined as mean lifespan. The statistical significance 
of lifespan between the strains can be found using a log rank analysis by Oasis software.40 
 
 









 Traditional thinking has labelled lipids to be detrimental given their 
association with many age-related diseases, however, numerous studies, including work 
done in our laboratory, has shown that lipid metabolism regulates aging and longevity, thus 
continued research is crucial.49 The purpose of this investigation was to (a) determine 
whether levels of ATGL-1 is increased by CeTOR inhibition using rapamycin and RNAi, 
and (b) to determine the role of ATGL-1 in CeTOR regulated longevity in C. elegans. This 
experiment has illustrated some important and interesting preliminary results, further 
research should be conducted.  
The significant and nonsignificant findings found using the fluorescent ATGL-
1::GFP levels in the control and rapamycin treated C. elegans could be attributed to small 
sample size and/or large inter-worm variation. Repeating this experiment with 
confirmation that rapamycin treatment is effective and inhibiting CeTOR, would allow 
more concise and potentially significant results to be found. The results of the Oil-Red-O 
staining to ensure the rate of lipolysis is increased may prove to be crucial for future 
experiments. It is possible that 24- and 48-hour treatment is not the ideal exposure time to 
observe an increase in ATGL-1, however, longevity experiments using C. elegans maintain 
the worms on rapamycin throughout the entire experiment. Thus, it is unlikely that the 
exposure time plays a large role in these unexpected results.  
CeTOR inhibition through rapamycin treatment and RNAi feeding may result in 
increased ATGL-1 expression shown by RT-qPCR, fluorescent microscopy of GFP and 
western blot. These findings would indicate that CeTOR inhibition increases ATGL-1 
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expression. Previous studies have shown mTORC1 inhibition by rapamycin within 
cultured mouse adipocytes, result in increased lipolysis in response to 𝛽 -adrenergic 
stimulation via enhanced HSL phosphorylation and by activation of Egr1-dependent 
ATGL transcription.42 However, within adipose deposits from adipose specific Raptor 
knockout (RaptoraKO) mice, there was no significant increase in ATGL protein 
expression.42,44,46,46,47 The results of the Oil-Red-O staining will indicate whether or not 
lipolysis is increased with these two CeTOR inhibitory methods and future experiments 
based on these results can then be conducted. Evidence would suggest this increase in 
lipolysis is due to an increase in expression and activity of ATGL-1, however, the 
preliminary results found in this experiment do not support this theory. The rapamycin and 
CeTOR specific RNAi inhibition used here may be explained similarly to those explained 
by (Paolella et al., 2020) in the RaptoraKO mice.  
Suppression of PPAR𝛾 and C/EBP𝛼 transcriptional activity by TORC1 inhibition 
may account for the increased lipolytic rate. Germline ablation of the C/EBP𝛼  target 
perilipin 1 as well as RaptoraKO exhibit increased basal lipolysis and decreased stimulated 
lipolysis.51 In addition, mice treated with rapamycin show decreased expression of perilipin 
1. Perilipin 1 coats the outside of lipid droplets and mediates the access of ATGL and HSL 
to lipid droplets. Therefore, decreased perilipin 1 expression within these mice could 
explain an increase in ATGL-dependent lipolysis without an increase in ATGL-1.42 The 
lipolytic pathway in mammals and C. elegans with the ATGL activator ABHD5, which is 
controlled by PKA, is shown in Figure 8. C. elegans have close homologues of each 
protein within the lipolytic pathway. First identified as W01A8.1 and now plin-1, has been 
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recognized as the nematode’s perilipin-related protein.52 Though the complete function is 
not fully understood, further experimentation in C. elegans is necessary. Perhaps CeTOR 
inhibition by rapamycin and RNAi has similar effects on the perilipin-related protein and 
therefore, though an increase in lipolysis is observed, an increase in ATGL-1 is not. 
Repeating this experiment with quantification of the perilipin-related protein may aid in 




Figure 8. Lipolytic enzymes and regulatory proteins.  
Mammalian proteins are shown above the arrows and their corresponding C. elegans 
orthologues are below. The lipolytic pathway includes adipose triacylglycerol lipase 
(ATGL), hormone-sensitive lipase (HSL) and monoacylglycerol lipase (MGL). These 
lipases act on triacylglycerol (TAG), diacylglycerol (DAG) and monoacylglycerol (MAG), 
respectively. LID-1 and C37H5.3 were proposed to be orthologues of ABHD5/CGI58 in 
C. elegans (Lee et al., 2014: Xie & Roy, 2015).34,35 Under control of protein kinase A 
(PKA), Perilipin regulates the access of ATGL and HSL to lipid droplets. Plin-1 is 




Using the results from the expression of ATGL experiments, the next question is 
the impact ATGL-1 has on CeTOR regulated longevity. In order for this to be assessed, 
CeTOR inhibition by both rapamycin and RNAi feeding methodology used here would 
have to prove to be effective in increasing longevity within C. elegans compared to 
nontreated worms, both of which have previously proven to be successful. Once our 
methodology is confirmed and working as expected, the atgl-1 mutant can be utilized to 
determine whether or not ATGL-1 is required for the longevity response of CeTOR 
inhibition. If these results reveal that the life extension of CeTOR inhibition is decreased 
within the atgl-1 mutant, it may be feasible to conclude that ATGL-1 is required in the 
CeTOR regulated longevity response. These results may also highlight the important 
impact ATGL-1 has downstream of CeTOR regulated longevity within C. elegans. 
Together, these results would agree with our previous findings that dietary restriction and 
IIS pathways converge on ATGL-1 expression and that ATGL-1 is required for the life 
extension response of dietary restriction and both critical nodes within the insulin/IGF1 
signaling pathway. Given that these pathways, as well as the enzymes involved, are 
evolutionarily conserved from yeast to primates, these findings may have a direct impact 
on future human longevity research.  
Adipose tissue plays an important role in the regulation of energy homeostasis and 
lifespan. The balance by which this is accomplished is through opposing anabolic and 
catabolic processes. Caloric/dietary restriction decreases triglyceride storage within 
adipocytes and extends life, on the other hand, obesity, has been shown to have the opposite 
effect. Lipolysis is elevated by inflammatory cytokines, natriuretic peptides, growth 
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hormones, and cortisol, in addition to	𝛽-adrenergic stimulation.15 The products of the 
lipolytic pathway are DAG, MAG, fatty acids and glycerol. These products are 
differentially utilized depending on the tissue. In vitro data from mice adipocytes has 
indicated that products or a specific lipolytic product may inhibit TOR, which suggests that 
they may facilitate catecholamine-induced inhibition of glucose uptake within adipocytes. 
In addition, it was found that ATGL was required for both TORC1 and TORC2 
dissociation. Thus, the way in which the lipolytic pathway product(s) inhibit TOR was 
found to be through complex dissociation.15  
ATGL is highly expressed within adipose tissue, although it is also expressed 
within several other tissues including skeletal muscle, liver, heart, testes, lung, retina, 
immune cells, pancreas, small intestine and the brain.41 The brain has the second highest 
lipid content second to adipose tissue. In contrast to peripheral tissues, the brain utilizes 
glucose as its main energy source. Therefore, lipids play crucial roles in nervous system 
structure and function and various signaling processes. For example, central regulation of 
energy homeostasis requires FA availability within the hypothalamus. Though 
understanding of ATGL within the brain is incomplete, it has been found that ATGL may 
be required for transport of FA across the brain-CSF interface, the brain-CSF barrier and 
the blood brain barrier. This indicates that the products of lipolysis within the brain and 
their metabolites may serve as important second messengers.43  
Tissue specific regulation of ATGL expression has already been shown to be 
implicated in chronic disease research and in longevity studies. However, there are still 
many insights to be discovered and understood about its role in longevity pathways, 
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including the feedback mechanism and second messengers lipolytic products play. Further 
research on ATGL may prove to have a major impact on future chronic disease research 
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